FDA Approves MYCOPHENOLATE MOFETIL — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

# FDA Approves Heritage Pharmaceuticals' Generic Mycophenolate Mofetil Heritage Pharmaceuticals Inc. (operating as Avet Pharmaceuticals Inc.) has received FDA approval for its generic formulation of mycophenolate mofetil, an immunosuppressant used in transplant patients, potentially intensifying competition in the established market for this widely-prescribed therapeutic agent. The approval of the oral formulation could increase price competition and expand patient access to this critical immunosuppressive medication.